Pharmacokinetics of pimobendan after oral administration to dogs with myxomatous mitral valve disease
McManamey, A. K., DeFrancesco, T. C., Meurs, K. M., & Papich, M. G. (2023, September 30). JOURNAL OF VETERINARY INTERNAL MEDICINE.
author keywords: canine; heart failure; valvular heart disease; Vetmedin
TL;DR:
The pharmacokinetic parameters were highly variable among this group of dogs with MMVD, and the variability was not associated with the dog's age, body weight or condition score, stage of heart disease, dose, serum creatinine, or alkaline phosphatase.
(via
Semantic Scholar)
UN Sustainable Development Goal Categories